Close Menu

Wake Forest University

The program, called Project Facilitate, aims to help oncologists request access to investigational drugs but may only simplify part of the process.

The researchers found differences in mutational patterns among their African-American patients and that liquid biopsies seem to catch metastases early.

An international team of researchers also suggested that MUC16 mutations could identify patients who might benefit from immunotherapy treatment.